Literature DB >> 25534940

Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.

Thiago Marconi Cardoso1, Álvaro Machado2, Diego Luiz Costa3, Lucas P Carvalho1, Adriano Queiroz1, Paulo Machado1, Phillip Scott4, Edgar M Carvalho1, Olívia Bacellar5.   

Abstract

Cutaneous leishmaniasis (CL) caused by Leishmania braziliensis is characterized by a strong Th1 response that leads to skin lesion development. In areas where L. braziliensis transmission is endemic, up to 15% of healthy subjects have tested positive for delayed-type hypersensitivity to soluble leishmania antigen (SLA) and are considered to have subclinical (SC) infection. SC subjects produce less gamma interferon (IFN-γ) and tumor necrosis factor alpha (TNF-α) than do CL patients, but they are able to control the infection. The aim of this study was to characterized the role of CD8(+) T cells in SC infection and in CL. Peripheral blood mononuclear cells (PBMC) were stimulated with SLA to determine the frequencies of CD4(+) IFN-γ(+) and CD8(+) IFN-γ(+) T cells. Monocytes from PBMC were infected with L. braziliensis and cocultured with CD8(+) T cells, and the frequencies of infected monocytes and levels of cytotoxicity markers, target cell apoptosis, and granzyme B were determined. The frequency of CD8(+) IFN-γ(+) cells after SLA stimulation was higher for SC individuals than for CL patients. The frequency of infected monocytes in SC cells was lower than that in CL cells. CL CD8(+) T cells induced more apoptosis of infected monocytes than did SC CD8(+) T cells. Granzyme B production in CD8(+) T cells was higher in CL than in SC cells. While the use of a granzyme B inhibitor decreased the number of apoptotic cells in the CL group, the use of z-VAD-FMK had no effect on the frequency of these cells. These results suggest that CL CD8(+) T cells are more cytotoxic and may be involved in pathology.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25534940      PMCID: PMC4333467          DOI: 10.1128/IAI.02404-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis.

Authors:  Daniela R Faria; Kenneth J Gollob; José Barbosa; Albert Schriefer; Paulo R L Machado; Hélio Lessa; Lucas P Carvalho; Marco Aurélio Romano-Silva; Amélia R de Jesus; Edgar M Carvalho; Walderez O Dutra
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Phenotyping of circulating CD8⁺ T cell subsets in human cutaneous leishmaniasis.

Authors:  Ali Khamesipour; Mahmoud Nateghi Rostami; Minoo Tasbihi; Akram Miramin Mohammadi; Tahereh Shahrestani; Abdolfattah Sarrafnejad; Yahya Sohrabi; Seyed Ebrahim Eskandari; Hossein Keshavarz Valian
Journal:  Microbes Infect       Date:  2012-02-28       Impact factor: 2.700

3.  Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.

Authors:  R L Bottrel; W O Dutra; F A Martins; B Gontijo; E Carvalho; M Barral-Netto; A Barral; R P Almeida; W Mayrink; R Locksley; K J Gollob
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.

Authors:  Yasmine Belkaid; Esther Von Stebut; Susana Mendez; Rosalia Lira; Elisabet Caler; Sylvie Bertholet; Mark C Udey; David Sacks
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

Review 5.  Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology.

Authors:  Kenneth J Gollob; Lis R V Antonelli; Daniela R Faria; Tatjana S L Keesen; Walderez O Dutra
Journal:  Int Immunopharmacol       Date:  2008-10       Impact factor: 4.932

Review 6.  Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example.

Authors:  Christian Bogdan
Journal:  Cell Microbiol       Date:  2008-03-17       Impact factor: 3.715

Review 7.  Cell death mechanisms induced by cytotoxic lymphocytes.

Authors:  L Chávez-Galán; M C Arenas-Del Angel; E Zenteno; R Chávez; R Lascurain
Journal:  Cell Mol Immunol       Date:  2009-02       Impact factor: 11.530

8.  CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathy.

Authors:  Jaline Coutinho Silverio; Isabela Resende Pereira; Márcio da Costa Cipitelli; Nathália Ferreira Vinagre; Maurício Martins Rodrigues; Ricardo Tostes Gazzinelli; Joseli Lannes-Vieira
Journal:  PLoS Pathog       Date:  2012-04-19       Impact factor: 6.823

9.  Protective and pathologic immune responses in human tegumentary leishmaniasis.

Authors:  Lucas P Carvalho; Sara Passos; Albert Schriefer; Edgar M Carvalho
Journal:  Front Immunol       Date:  2012-10-04       Impact factor: 7.561

10.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.

Authors:  F P Heinzel; M D Sadick; B J Holaday; R L Coffman; R M Locksley
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  51 in total

1.  A Potential Role for Mononuclear Phagocytes in Cutaneous Ulcer Development in Human Immunodeficiency Virus-Leishmania braziliensis Coinfection.

Authors:  Luiz H Guimarães; Maíra Saldanha; Taís Menezes; Lis Moreno; Alex Torres; Rúbia Costa; Sara Passos; Roberto Badaró; Sérgio Arruda; Lucas P Carvalho
Journal:  Am J Trop Med Hyg       Date:  2015-10-19       Impact factor: 2.345

2.  CD8+ T Cells Lack Local Signals To Produce IFN-γ in the Skin during Leishmania Infection.

Authors:  Fernanda O Novais; Andrea C Wong; Daniel O Villareal; Daniel P Beiting; Phillip Scott
Journal:  J Immunol       Date:  2018-01-24       Impact factor: 5.422

3.  Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

Authors:  Augusto M Carvalho; Luiz H Guimarães; Rúbia Costa; Maíra G Saldanha; Iana Prates; Lucas P Carvalho; Sérgio Arruda; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

4.  Immunologic Markers of Protection in Leishmania (Viannia) braziliensis Infection: A 5-Year Cohort Study.

Authors:  Aline C Muniz; Olívia Bacellar; Ednaldo Lima Lago; Augusto M Carvalho; Pedro Paulo Carneiro; Luiz Henrique Guimarães; Paulo N Rocha; Lucas P Carvalho; Marshall Glesby; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2016-05-18       Impact factor: 5.226

5.  Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis.

Authors:  Camila Farias Amorim; Fernanda O Novais; Ba T Nguyen; Ana M Misic; Lucas P Carvalho; Edgar M Carvalho; Daniel P Beiting; Phillip Scott
Journal:  Sci Transl Med       Date:  2019-11-20       Impact factor: 17.956

6.  Granzyme B Produced by Natural Killer Cells Enhances Inflammatory Response and Contributes to the Immunopathology of Cutaneous Leishmaniasis.

Authors:  Taís M Campos; Fernanda O Novais; Maíra Saldanha; Rúbia Costa; Morgana Lordelo; Daniela Celestino; Camilla Sampaio; Natália Tavares; Sérgio Arruda; Paulo Machado; Cláudia Brodskyn; Phillip Scott; Edgar M Carvalho; Lucas P Carvalho
Journal:  J Infect Dis       Date:  2020-03-02       Impact factor: 5.226

7.  Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.

Authors:  H Kaushal; R Bras-Gonçalves; K Avishek; D Kumar Deep; E Petitdidier; J-L Lemesre; G Papierok; S Kumar; V Ramesh; P Salotra
Journal:  Clin Exp Immunol       Date:  2016-05-04       Impact factor: 4.330

8.  The Elderly Respond to Antimony Therapy for Cutaneous Leishmaniasis Similarly to Young Patients but Have Severe Adverse Reactions.

Authors:  Alexsandro Souza do Lago; Maurício Nascimento; Augusto M Carvalho; Neuza Lago; Juliana Silva; José Roberto Queiroz; Lucas P Carvalho; Albert Schriefer; Mary Wilson; Paulo Machado; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2018-03-22       Impact factor: 2.345

Review 9.  Cutaneous leishmaniasis: immune responses in protection and pathogenesis.

Authors:  Phillip Scott; Fernanda O Novais
Journal:  Nat Rev Immunol       Date:  2016-07-18       Impact factor: 53.106

10.  IL-1β Production by Intermediate Monocytes Is Associated with Immunopathology in Cutaneous Leishmaniasis.

Authors:  Daniela Santos; Taís M Campos; Maíra Saldanha; Sergio C Oliveira; Mauricio Nascimento; Dario S Zamboni; Paulo R Machado; Sérgio Arruda; Phillip Scott; Edgar M Carvalho; Lucas P Carvalho
Journal:  J Invest Dermatol       Date:  2017-12-12       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.